(717) 353-2014

  • Follow
  • Follow
  • Our Services
    • Reimbursement
    • Policy Analysis
    • Value Prop
  • Toolkits
    • MolDX Guide
    • HCPCS
    • CLFS
    • PLA Code
  • Insights
    • Medicare
    • Policy Archives
  • CONTACT
  • Our Services
    • Reimbursement
    • Policy Analysis
    • Value Prop
  • Toolkits
    • MolDX Guide
    • HCPCS
    • CLFS
    • PLA Code
  • Insights
    • Medicare
    • Policy Archives
  • CONTACT

KFF Health Tracking Poll: Balancing Efficiency and Public Sentiment

by John Warren | Jan 22, 2025

As federal healthcare spending comes under scrutiny amid calls for broader fiscal responsibility, findings from the January 2025 KFF Health Tracking Poll shed light on Americans’ priorities. This moment presents a dual challenge for the Administration: aligning its...

Digital Mental Health Treatment: Here Are 4 Fundamentals You Have to Know to Uncomplicate CMS’s Proposed Policy

by John Warren | Jul 22, 2024

The Centers for Medicare & Medicaid Services (CMS) recently unveiled a proposal in the 2025 Medicare Physician Fee Schedule to cover Digital Mental Health Treatment (DMHT) devices. This policy marks a significant step towards integrating digital health...

Gene Therapy: The Unexpected Twist That Could Unlock Massive Medicare Payment Bumps

by John Warren | Apr 16, 2024

In their FY 2025 Inpatient Prospective Payment System proposed rule, CMS proposes a policy that would increase Medicare payment for gene therapy targeting sickle cell disease. CMS asserts that these additional New Technology Add-on Payments would increase access to...

The Little-Known Rule That Could Disrupt the Medicare Essential Medicines Market

by John Warren | Apr 15, 2024

As a part of the CMS FY 2025 Inpatient Prospective Payment System proposed rule, CMS followed up on its promise from last year to propose policies that would help the hospital industry to maintain access to essential medicines. But could this Medicare Essential...

© 2025 Gettysburg Healthcare Consulting, Inc.   All Rights Reserved.

  • Follow
  • Follow

Privacy